Relapsed Mycosis Fungoides/Sezary Syndrome
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12498 | Mogamulizumab | A monoclonal antibody used to treat relapsed or refractory mycosis fungoides or Sézary syndrome after attempting one other therapy. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB12498 | Mogamulizumab | C-C chemokine receptor type 4 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|